Giacco F, Brownlee M. Oxidative stress and diabetic complications. Circ Res. 2010;107:1058–70.
Article
CAS
PubMed
PubMed Central
Google Scholar
Vlassara H, Striker GE. Advanced glycation endproducts in diabetes and diabetic complications. Endocrinol Metab Clin North Am. 2013;42:697–719.
Article
PubMed
Google Scholar
Verzijl N, DeGroot J, Thorpe SR, et al. Effect of collagen turnover on the accumulation of advanced glycation end products. J Biol Chem. 2000;275:39027–31.
Article
CAS
PubMed
Google Scholar
Meerwaldt R, Graaf R, Oomen PHN, et al. Simple non-invasive assessment of advanced glycation endproduct accumulation. Diabetologia. 2004;47:1324–30.
Article
CAS
PubMed
Google Scholar
Felipe DL, Hempe JM, Liu S, et al. Skin intrinsic fluorescence is associated with hemoglobin A(1c) and hemoglobin glycation index but not mean blood glucose in children with type 1 diabetes. Diabetes Care. 2011;34:1816–20.
Article
PubMed
PubMed Central
Google Scholar
Conway BN, Aroda VR, Maynard JD, Matter N, Fernandez S, Ratner RE, Orchard TJ. Skin intrinsic fluorescence correlates with autonomic and distal symmetrical polyneuropathy in individuals with type 1 diabetes. Diabetes Care. 2011;34(4):1000–5.
Article
PubMed
PubMed Central
Google Scholar
Monnier VM, Bautista O, Kenny D, et al. Skin collagen glycation, glycoxidation, and crosslinking are lower in subjects with long-term intensive versus conventional therapy of type 1 diabetes: relevance of glycated collagen products versus HbA1c as markers of diabetic complications. DCCT Skin Collagen Ancillary Study Group. Diabetes Control and Complications Trial. Diabetes. 1999;48:870–80.
Article
CAS
PubMed
PubMed Central
Google Scholar
Meerwaldt R, Lutgers HL, Links TP, et al. Skin autofluorescence is a strong predictor of cardiac mortality in diabetes. Diabetes Care. 2007;30:107–12.
Article
CAS
PubMed
Google Scholar
Januszewski AS, Sachithanandan N, Karschimkus C, et al. Non-invasive measures of tissue autofluorescence are increased in Type 1 diabetes complications and correlate with a non-invasive measure of vascular dysfunction. Diabet Med. 2012;29:726–33.
Article
CAS
PubMed
Google Scholar
Nathan DM, DCCT/EDIC Research Group. The Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications study at 30 years: overview. Diabetes Care. 2014;37:9–16.
Article
CAS
PubMed
Google Scholar
James S, Gallagher R, Dunbabin J, et al. Prevalence of vascular complications and factors predictive of their development in young adults with type 1 diabetes: systematic literature review. BMC Res Notes. 2014;7:593.
Article
CAS
PubMed
PubMed Central
Google Scholar
Shah S, Báez EA, Felipe DL, et al. Advanced glycation endproducts in children with diabetes. J Pediatr. 2013;163:1427–31.
Article
CAS
PubMed
Google Scholar
Báez EA, Shah S, Felipe D, et al. Skin advanced glycation endproducts are elevated at onset of type 1 diabetes in youth. J Pediatr Endocrinol Metab. 2015;28:133–17.
Article
PubMed
Google Scholar
Barat P, Cammas B, Lacoste A, et al. Advanced glycation end products in children with type 1 diabetes: family matters? Diabetes Care. 2012;35:e1.
Article
PubMed
Google Scholar
Banser A, Naafs JC, Hoorweg-Nijman JJ, van de Garde EM, van der Vorst MM. Advanced glycation end products, measured in skin, vs. HbA1c in children with type 1 diabetes mellitus. Pediatr Diabetes. 2015. [Epub ahead of print]
Fredriks AM, van Buuren S, Burgmeijer RJ, et al. Continuing positive secular growth change in The Netherlands 1955–1997. Pediatr Res. 2000;47:316–23.
Article
CAS
PubMed
Google Scholar
Cole TJ, Bellizzi MC, Flegal KM, et al. Establishing a standard definition for child overweight and obesity worldwide: international survey. BMJ. 2000;320:1240–3.
Article
CAS
PubMed
PubMed Central
Google Scholar
Van Wieringen JC, Roede MJ, Wit JM. Growth diagrams for patient care [article in Dutch]. Tijdschr Kindergeneeskd. 1985;53:147–52.
PubMed
Google Scholar
National High Blood Pressure Education Program Working Group on Hypertension Control in Children and Adolescents. Update on the 1987 Task Force Report on High Blood Pressure in Children and Adolescents: a working group report from the National High Blood Pressure Education Program. Pediatrics. 1996;98:649–58.
Google Scholar
Rewers MJ, Pillay K, de Beaufort C, Craig ME, Hanas R, Acerini CL, Maahs DM, International Society for Pediatric and Adolescent Diabetes. ISPAD Clinical Practice Consensus Guidelines 2014. Assessment and monitoring of glycemic control in children and adolescents with diabetes. Pediatr Diabetes. 2014;15 Suppl 20:102–14.
Article
CAS
PubMed
Google Scholar
Lutgers HL, Graaff R, Links TP, et al. Skin autofluorescence as a noninvasive marker of vascular damage in patients with type 2 diabetes. Diabetes Care. 2006;29:2654–9.
Article
PubMed
Google Scholar
Sugisawa E, Miura J, Iwamoto Y, et al. Skin autofluorescence reflects integration of past long-term glycemic control in patients with type 1 diabetes. Diabetes Care. 2013;36:2339–45.
Article
CAS
PubMed
PubMed Central
Google Scholar
Vlassara H, Uribarri J. Advanced glycation end products (AGE) and diabetes: cause, effect, or both? Curr Diab Rep. 2014;14:453.
Article
PubMed
PubMed Central
Google Scholar
Meerwaldt R, Hartog JW, Graaff R, et al. Skin autofluorescence, a measure of cumulative metabolic stress and advanced glycation end products, predicts mortality in hemodialysis patients. J Am Soc Nephrol. 2005;16:3687–93.
Article
CAS
PubMed
Google Scholar
Salonen KM, Ryhänen SJ, Forbes JM, Finnish Pediatric Diabetes Register, et al. Circulating concentrations of soluble receptor for AGE are associated with age and AGER gene polymorphisms in children with newly diagnosed type 1 diabetes. Diabetes Care. 2014;37:1975–81.
Article
CAS
PubMed
Google Scholar
Eny KM, Lutgers HL, Maynard J, LifeLines Cohort Study Group, DCCT/EDIC Research Group, et al. GWAS identifies an NAT2 acetylator status tag single nucleotide polymorphism to be a major locus for skin fluorescence. Diabetologia. 2014;57:1623–34.
Article
CAS
PubMed
PubMed Central
Google Scholar
Baynes JW, Thorpe SR. Role of oxidative stress in diabetic complications: a new perspective on an old paradigm. Diabetes. 1999;48:1–9.
Article
CAS
PubMed
Google Scholar
Ceriello A, Novials A, Ortega E, Canivell S, La Sala L, Pujadas G, Esposito K, Giugliano D, Genovese S. Glucagon-like peptide 1 reduces endothelial dysfunction, inflammation, and oxidative stress induced by both hyperglycemia and hypoglycemia in type 1 diabetes. Diabetes Care. 2013;36(8):2346–50.
Article
CAS
PubMed
PubMed Central
Google Scholar
Sun JK, Keenan HA, Cavallerano JD, Asztalos BF, Schaefer EJ, Sell DR, Strauch CM, Monnier VM, Doria A, Aiello LP, King GL. Protection from retinopathy and other complications in patients with type 1 diabetes of extreme duration: the joslin 50-year medalist study. Diabetes Care. 2011;34(4):968–74.
Article
PubMed
PubMed Central
Google Scholar
Conway BN, Maynard JD, Orchard TJ. Comment on: Sun et al. Protection from retinopathy and other complications in patients with type 1 diabetes of extreme duration: the Joslin 50-Year Medalist Study. Diabetes Care 2011;34:968–974. Diabetes Care. 2011;34(9):e148. author reply e149.
Article
PubMed
PubMed Central
Google Scholar
Koetsier M, Lutgers HL, De Jonge C, et al. Reference values of skin autofluorescence. Diabetes Technol Ther. 2010;12:399–403.
Article
CAS
PubMed
Google Scholar
Noordzij MJ, Lefrandt JD, Graaff R, et al. Dermal factors influencing measurement of skin autofluorescence. Diabetes Technol Ther. 2011;13:165–70.
Article
PubMed
Google Scholar
Poulsen MW, Hedegaard RV, Andersen JM, et al. Advanced glycation endproducts in food and their effects on health. Food Chem Toxicol. 2013;60:10–37.
Article
CAS
PubMed
Google Scholar
Den Engelsen C, van den Donk M, Gorter KJ, et al. Advanced glycation end products measured by skin autofluorescence in a population with central obesity. Dermatoendocrinol. 2012;4:33–3.
Article
Google Scholar